Management of Blood Glucose Level of 500 mg/dL
A blood glucose level of 500 mg/dL requires immediate medical attention and treatment with insulin therapy to prevent progression to diabetic ketoacidosis (DKA), which is a life-threatening condition. 1, 2
Initial Assessment
- Evaluate for symptoms of hyperglycemia such as thirst, frequent urination, blurry vision, and assess for more severe symptoms including nausea, vomiting, abdominal pain, and altered mental status 1, 2
- Check for ketones in blood or urine to assess for diabetic ketoacidosis 2, 3
- Assess vital signs, hydration status, and level of consciousness 3
- Evaluate for precipitating factors such as infection, medication non-adherence, or new-onset diabetes 2, 3
Immediate Management
Fluid Resuscitation
- Begin with isotonic saline (0.9% NaCl) at 15-20 mL/kg/hr to restore circulatory volume and tissue perfusion 2, 3
- After the first hour, continue fluid replacement based on hemodynamic status, typically at 4-14 mL/kg/hr 2
- Adequate fluid intake is crucial as dehydration increases the risk of complications and hospitalization 2, 4
Insulin Therapy
- For critically ill patients or those with severe hyperglycemia (>500 mg/dL), intravenous insulin infusion is the preferred method 1
- Start continuous intravenous regular insulin at 0.1 units/kg/hr after fluid resuscitation has begun 2, 3
- If glucose does not fall by 50-75 mg/dL in the first hour, double the insulin infusion rate 2, 3
- Once blood glucose reaches 200-250 mg/dL, add dextrose to IV fluids while continuing insulin infusion to prevent hypoglycemia 2, 3
Electrolyte Management
- Monitor serum potassium levels every 2-4 hours as insulin therapy can cause hypokalemia 2, 3
- Begin potassium replacement when serum levels fall below 5.2 mEq/L, provided the patient has adequate urine output 2, 3
- Typical potassium replacement is 20-30 mEq per liter of IV fluid 2, 3
Ongoing Monitoring
- Check blood glucose every 1-2 hours until stable 2, 3
- Monitor electrolytes, blood urea nitrogen, creatinine, and venous pH every 2-4 hours 2, 3
- Assess for signs of cerebral edema, particularly in children and adolescents 2, 3
- Watch for symptoms of hypoglycemia during treatment including sweating, drowsiness, dizziness, anxiety, tremor, and hunger 5
For Non-Critical Hyperglycemia (Outpatient Setting)
If the patient is alert, not in distress, and without signs of DKA:
- Administer subcutaneous rapid-acting insulin at an appropriate dose (typically 0.1-0.2 units/kg) 1
- Ensure adequate hydration with sugar-free fluids 1
- Monitor blood glucose levels every 1-2 hours 1
- Seek medical attention if symptoms worsen or blood glucose remains elevated 1, 5
Prevention of Future Episodes
- Review sick-day management with patients, including when to contact healthcare providers 2, 3
- Advise patients never to discontinue insulin during illness and to seek professional advice early 2, 3
- Educate patients on monitoring blood glucose and urine ketones when blood glucose is >300 mg/dL 2, 3
Complications to Watch For
- Diabetic ketoacidosis: characterized by nausea, vomiting, abdominal pain, and high ketone levels 1, 5
- Hyperosmolar hyperglycemic state: extreme hyperglycemia without significant ketosis, often with altered mental status 4
- Cerebral edema: more common in children, presenting with headache, altered mental status, seizures 2, 3
- Hypokalemia during insulin treatment: can lead to cardiac arrhythmias 5
Pitfalls to Avoid
- Using only sliding scale insulin (SSI) as the sole method of treatment is strongly discouraged as it is reactive rather than preventative 1
- Failing to identify and treat the underlying cause of hyperglycemia 2, 3
- Neglecting to monitor for hypoglycemia when insulin therapy is initiated 5
- Discontinuing insulin therapy too early before the hyperglycemic crisis is fully resolved 2, 3